Jacobs Levy Equity Management’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-22,170
| Closed | -$197K | – | 1036 |
|
|
2019
Q3 | $197K | Buy |
22,170
+7,375
| +50% | +$65.5K | ﹤0.01% | 846 |
|
|
2019
Q2 | $211K | Buy |
14,795
+9,217
| +165% | +$131K | ﹤0.01% | 872 |
|
|
2019
Q1 | $183K | Buy |
5,578
+1,434
| +35% | +$47K | ﹤0.01% | 906 |
|
|
2018
Q4 | $246K | Sell |
4,144
-3,930
| -49% | -$233K | ﹤0.01% | 842 |
|
|
2018
Q3 | $1.13M | Sell |
8,074
-217
| -3% | -$30.5K | 0.02% | 629 |
|
|
2018
Q2 | $1.02M | Buy |
8,291
+4,494
| +118% | +$552K | 0.02% | 661 |
|
|
2018
Q1 | $339K | Sell |
3,797
-567
| -13% | -$50.6K | 0.01% | 845 |
|
|
2017
Q4 | $242K | Sell |
4,364
-676
| -13% | -$37.5K | ﹤0.01% | 873 |
|
|
2017
Q3 | $213K | Buy |
5,040
+508
| +11% | +$21.5K | ﹤0.01% | 849 |
|
|
2017
Q2 | $191K | Buy |
4,532
+3,100
| +216% | +$131K | ﹤0.01% | 850 |
|
|
2017
Q1 | $80K | Sell |
1,432
-1,001
| -41% | -$55.9K | ﹤0.01% | 871 |
|
|
2016
Q4 | $93K | Buy |
+2,433
| New | +$93K | ﹤0.01% | 910 |
|